Spartalizumab (anti-PD-1)
Spartalizumab (anti-PD-1) is a humanized anti-PD-1 IgG4 antibody that blocks the binding of PD-L1 and PD-L2 to PD-1. It binds to PD-1 with high affinity and inhibits the biological activity of PD-1, MW: 145.8 KD.
Supplier | Selleck Chemicals |
---|---|
Product # | A2017 |
Sku # | A2017-1mg*5 |
Pricing | 1mg*5, $707.00 |